MAP2K7 and cancer: We found knockdown of BCAT1 significantly reduced the activities of Ras/BRaf/MEK/ERK signalling kinases in SCLC cells (Figure 5E), indicating this pathway is involved in BCAT1‐mediated cancer cell proliferation.